Quantitative serum PCR argues against long-term persistence of HHV-6 viremia after umbilical cord blood transplantation

Maryam Ebadi, Justin Wasko, Daniel J. Weisdorf, Jeffrey S. Miller, Armin Rashidi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article numbere13555
JournalTransplant Infectious Disease
Volume23
Issue number3
DOIs
StatePublished - Jun 2021

Bibliographical note

Funding Information:
We acknowledge the Translational Therapy Laboratory of the University of Minnesota for providing research samples and Coppe Laboratories for performing PCR assays. Research reported in this publication was supported by the NIH grants P30CA077598 utilizing the Biostatistics Core shared resource of the Masonic Cancer Center (University of Minnesota) and UL1-TR002494. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Funding Information:
We acknowledge the Translational Therapy Laboratory of the University of Minnesota for providing research samples and Coppe Laboratories for performing PCR assays. Research reported in this publication was supported by the NIH grants P30CA077598 utilizing the Biostatistics Core shared resource of the Masonic Cancer Center (University of Minnesota) and UL1‐TR002494. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Keywords

  • HHV-6
  • PCR
  • cord blood transplantation
  • viremia

Cite this